关于公司实际控制人、董事长被留置的公告 证券代码：002365 证券简称：永安药业 公告编号：2025-31 潜江永安药业股份有限公司 目前，公司尚未知悉上述事项的进展和结论，公司将持续关注上述事项的 进展情况，并严格按照相关规定及时履行信息披露义务。 公司指定信息披露媒体为《证券时报》、《中国证券报》、《上海证券报》 和巨潮资讯网，公司发布的信息均以在上述媒体刊登的公告为准。敬请广大投 资者注意投资风险。 特此公告。 潜江永安药业股份有限公司 董 事 会 二〇二五年五月五日 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 潜江永安药业股份有限公司（以下简称"公司"）收到公司实际控制人、董 事长陈勇先生家属的通知，其于近日收到由鹤峰县监察委员会签发的关于陈勇 先生的《立案通知书》和《留置通知书》，公司实际控制人、董事长陈勇先生被 立案调查并实施留置。 目前，公司已对相关工作进行了妥善安排。公司拥有完善的治理结构及内 部控制机制，将按照《公司法》、《深圳证券交易所股票上市规则》、《上市公 司治理准则》及《公司章程》等法律法规和相关制度规范运作。 截至本公告披露日 ...

智通财经5月5日电，永安药业(002365.SZ)公告称，公司收到实际控制人、董事长陈勇家属通知，陈勇 被鹤峰县监察委员会立案调查并实施留置。目前公司其他董事、监事和高级管理人员均正常履职，公司 控制权未发生变化，生产经营情况正常。公司将持续关注该事项进展并及时履行信息披露义务。 永安药业：公司实际控制人、董事长陈勇被立案调查并实施留置 ...

Mergers and Acquisitions - Zhongguangtianze plans to acquire 100% equity of Changsha Sports Industry Company for 29.6 million yuan, constituting a related party transaction [1] Earnings Disclosure - JinkoSolar reported a revenue of 13.843 billion yuan for Q1 2025, a year-on-year decrease of 40.03%, with a net loss of 1.39 billion yuan compared to a net profit of 1.176 billion yuan in the same period last year [2] - Zhongjin Gold reported a revenue of 14.859 billion yuan for Q1 2025, a year-on-year increase of 12.88%, with a net profit of 1.038 billion yuan, up 32.65% year-on-year [3] - Northern Rare Earth achieved a revenue of 9.287 billion yuan for Q1 2025, a year-on-year increase of 61.19%, with a net profit of 431 million yuan, up 727.3% year-on-year [4] - Kweichow Moutai reported a revenue of 50.601 billion yuan for Q1 2025, a year-on-year increase of 10.54%, with a net profit of 26.847 billion yuan, up 11.56% year-on-year [5] Share Buybacks - Shanjin International plans to repurchase shares with a total amount between 100 million and 200 million yuan at a price not exceeding 29.7 yuan per share [6] - Sichuan Road and Bridge plans to repurchase shares with a total amount between 100 million and 200 million yuan at a price not exceeding 12.54 yuan per share [7] - China Railway plans to repurchase shares with a total amount between 800 million and 1.6 billion yuan at a price not exceeding 8.5 yuan per share [8] - Anhui Construction's controlling shareholder plans to increase its stake in the company with a total amount not exceeding 200 million yuan [9][10] Risk Matters - Chuangxing Resources' stock will be subject to delisting risk warning starting May 6, 2025, due to negative net profit for the fiscal year 2024 [11] - Yong'an Pharmaceutical clarified that rumors regarding a significant price increase of taurine are untrue [12] - *ST Xulan's stock will be delisted on April 30, 2025, as decided by the Shenzhen Stock Exchange [13] - Dawi Technology's shareholder plans to reduce its stake by up to 3% of the company's total shares due to personal financial needs [14]

近日，潜江永安药业股份有限公司（以下简称"公司"）收到国家知识产权 局颁发的一项发明专利证书，具体内容如下: 证券代码：002365 证券简称：永安药业 公告编号：2025-30 潜江永安药业股份有限公司 关于取得发明专利证书的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 专利申请日：2022 年 06 月 22 日 授权公告日：2025 年 04 月 29 日 授权公告号：CN 115141126 B 专利有效期：从申请日开始 20 年 公司为全球牛磺酸领域的知名企业，一直致力于牛磺酸生产技术的研发，该 专利的取得有利于保护和发挥公司主导产品自主知识产权优势，使公司继续在 牛磺酸领域保持技术领先优势,有利于提升公司的核心竞争力，进一步提高公司 牛磺酸产品在国际市场的知名度。该专利的取得暂不会对公司生产经营和业绩 产生重大影响。 特此公告。 发明名称：一种高效循环制备柱状牛磺酸的方法 发明人：陈勇；方锡权；李少波 专利号：ZL 2022 1 0720762.3 专利权人：潜江永安药业股份有限公司 地址：433100 湖北省潜江市潜江经济开发区广泽大道 ...

证券代码：002365 证券简称：永安药业 公告编号：2025-29 潜江永安药业股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 除上述事项外，公司未发现近期公共媒体报道了可能或者已经对公司股票交易 价格产生较大影响的未公开重大信息。 （三）经核查，公司近期经营情况正常，内外部经营环境未发生重大变化。 （四）经核查，公司、控股股东和实际控制人不存在关于本公司的应披露而 未披露的重大事项，或处于筹划阶段的重大事项；股票异常波动期间控股股东、 实际控制人不存在买卖公司股票的行为。 （五）经核查，公司未发现其他应披露而未披露事项。 一、股票交易异常波动的情况介绍 潜江永安药业股份有限公司（以下简称"公司"，证券简称：永安药业，证 券代码：002365）股票交易价格于 2025 年 4 月 28 日、2025 年 4 月 29 日连续两 个交易日内日收盘价格涨幅偏离值累计超出 20%，根据深圳证券交易所的有关规 定，属于股票交易异常波动的情况。 二、公司关注、核实情况说明 针对公司股票交易异常波动，公司董事会对公司、控股股东及实际控 ...

7天5板永安药业："牛磺酸价格暴涨几倍"等传闻不实 智通财经4月29日电，永安药业(002365.SZ)发布股票交易异常波动公告。近期网络上流传"牛磺酸价格 暴涨几倍"等传闻，经向公司有关部门了解，此等消息不实。 ...

Core Viewpoint - The company has reported on its first quarter financial results and various corporate actions, including share buybacks, legal proceedings, and new investments in subsidiaries, indicating a proactive approach to enhance shareholder value and operational capacity [3][5][6][9][10]. Financial Data - The first quarter report has not been audited, and the company confirms that there are no adjustments or restatements of previous financial data [3][12]. - The company has completed a share buyback program, repurchasing 5,537,350 shares, which is 1.88% of the total share capital, at a total cost of approximately 40.45 million yuan [5][8]. Shareholder Information - The company has not reported any changes in the top ten shareholders or any significant changes in share lending activities [5]. Legal Matters - The company is involved in a patent infringement lawsuit in the U.S. regarding its taurine products, but a favorable ruling was received in February 2024, with the plaintiff required to pay some legal fees. The plaintiff has since filed for bankruptcy, which has temporarily halted the appeal process [6]. Project Developments - The company is nearing completion of a project to expand its taurine food additive production capacity to 40,000 tons per year, with the project currently in the final construction and acceptance phase [8]. - A new wholly-owned subsidiary, Fuweile Pet Food (Wuhan) Co., Ltd., has been established with a registered capital of 2 million yuan, focusing on pet food and additives [9]. Investment Activities - The company has approved the use of up to 750 million yuan for wealth management investments, aiming to enhance the efficiency of idle funds while maintaining risk control [15][27][28]. - Additionally, the company has authorized up to 50 million yuan for securities investments, with a focus on enhancing returns on idle funds [40][41][42]. Related Transactions - The company has entered into a framework agreement with Zhejiang Twin Intelligent Equipment Co., Ltd. for equipment manufacturing and system integration services, with a total transaction amount not exceeding 10 million yuan [55][56].

登录新浪财经APP 搜索【信披】查看更多考评等级 （一）合作范围 1、由于乙方是甲方的关联方，本协议项下交易构成关联交易。 2、为保障甲方及其控股子公司生产线自动化、智能化改造，保证甲方生产经营顺利进行，充分利用乙 方的人才、设备、技术优势，加快甲方项目进度，甲乙双方同意在项目进行过程中乙方为甲方提供如下 服务： （1）根据甲方提供的技术目标、技术内容等要求提供符合要求的设备； （2）根据甲方提供的质量控制及技术指标等要求为项目提供设备安装和配套的信息系统搭建、调试应 用等服务。 （二）交易原则及交易金额 1、甲乙双方一致同意，双方遵照公平合理、等价有偿、诚实信用的市场交易原则进行合作，不得损害 交易任何一方、特别是甲方非关联股东的利益。 2、本协议项下交易总金额不超过1,000万元。 3、交易价格核定的基本依据: （1）合同项下的内容，甲方进行充分的市场调研，并基于掌握的市场信息与乙方协商确定合同价格。 为达到甲方对项目的最终目标，所需材料及专用设备由乙方提供。 （2）乙方为甲方提供的设备及材料所需经费必须制定资金预算，经甲方批准确认后方可实施。 （3）甲、乙双方同意本协议项下的所有服务，具体的交易按本协议 ...

Performance Highlights - Several companies have shown significant stock performance driven by earnings reports, with notable increases such as 博创科技 (20.01%), 精进电动-UW (20.00%), and 蓝帆医疗 (10.02%) [2][3][4] - The stock market has seen a trend of first boards for many companies, indicating strong initial investor interest [2][3][4] Chemical Industry - Recent fluctuations in chemical product prices have attracted market attention, impacting related companies positively [5] - Companies like 先达股份 and 永安药业 have shown strong performance, with increases of 10.03% and 9.97% respectively, attributed to their involvement in chemical products [6] PEEK Materials - The report from 国金证券 indicates that the rise of humanoid robots will benefit upstream core chemical new materials, including PEEK and PA [7] - Stocks such as 聚赛龙 and 新潮新材 have experienced significant gains, with increases of 20.01% and 19.99% respectively, linked to PEEK materials [8] Robotics Sector - The robotics sector is gaining traction, with companies like 宁波东力 and 唯科科技 showing increases of 9.96% and 12.23% respectively, driven by advancements in robotics technology [11] - Predictions suggest that humanoid robots will enter mass production by 2026, further boosting the sector [10] Gold Investment - Recent volatility in gold prices has led to increased consumer interest, with reports of high demand for gold bars in wholesale markets [14] - Companies like 菜百股份 have seen stock increases of 10.00% due to their involvement in the gold and jewelry sector [15]

Market Overview - As of April 28, the Shanghai Composite Index closed at 3288.41 points, down 6.65 points, a decrease of 0.20% [1] - The Shenzhen Component Index closed at 9855.20 points, down 61.86 points, a decrease of 0.62% [1] - The ChiNext Index closed at 1934.46 points, down 12.73 points, a decrease of 0.65% [1] Stock Performance - A total of 75 A-shares had a turnover rate exceeding 20% on this day, indicating significant trading activity [1] - Notable stocks with high turnover rates included: - C Zhongjie (301560) with a turnover rate of 63.74% and a closing price of 39.91 yuan, down 13.43% [1] - Southern Road Machinery (603280) with a turnover rate of 52.78% and a closing price of 25.59 yuan, up 2.94% [1] - Victory Energy (001331) with a turnover rate of 44.52% and a closing price of 15.09 yuan, up 4.28% [1] Additional Notable Stocks - Other stocks with significant turnover rates included: - Zhejiang Huayuan (301535) with a turnover rate of 43.58%, closing at 18.41 yuan, down 11.91% [1] - Yong'an Pharmaceutical (002365) with a turnover rate of 39.92%, closing at 13.04 yuan, up 10.04% [1] - Hongqiang Co. (002809) with a turnover rate of 37.55%, closing at 11.83 yuan, down 3.11% [1]